Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefiderocol in Gram-negative Bloodstream Infection
NCT03869437Phase 2Completed
- Sponsor
- The University of Queensland
- Start
- Oct 2019
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of cefiderocol in bloodstream infection (BSI), sponsored by The University of Queensland. Started Oct 2019; status: completed.
02
Drugs
cefiderocol
03
Conditions
bloodstream infection (BSI)
Beyond the preview
Go deeper on NCT03869437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03869437.